Crescent Biopharma, Inc. · NASDAQ:CBIO
Tang Capital Management LLC's stake in Crescent Biopharma, Inc. fell to 4.21% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Tang Capital Management LLC's stake in Crescent Biopharma, Inc. fell to 4.21%, 1,160,000 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.21%
- Shares
- 1,160,000
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 4.21% | 1,160,000 |
| KEVIN TANG | 4.21% | 1,160,000 |
| TANG CAPITAL PARTNERS, LP | 2.24% | 616,477 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 1.64% | 451,619 |
| TANG CAPITAL PARTNERS III, INC | 0.33% | 91,904 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
Source
Related
- Crescent Biopharma, Inc.
- Tang Capital Management LLC
- Crescent Biopharma, Inc. shareholders
- Schedule 13G · Tang Capital Management LLC · Oct 9, 2025
- Form 4 · Brumm Joshua T · Sep 18, 2026
- Form 4 · McNeill Jonathan · Sep 18, 2026
- Form 4 · Lynch Ryan · Sep 18, 2026
- Form 4 · Pinkas Jan · Sep 18, 2026
- Form 4 · Im Ellie Eunkyung · Sep 18, 2026